NASDAQ:ALEC - Alector News Headlines

$15.00
-0.14 (-0.92 %)
(As of 08/25/2019 04:00 PM ET)
Today's Range
$14.88
Now: $15.00
$15.37
50-Day Range
$14.42
MA: $18.47
$22.00
52-Week Range
$13.64
Now: $15.00
$27.00
Volume172,223 shs
Average Volume317,490 shs
Market Capitalization$1.03 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Alector (NASDAQ ALEC) News Headlines

Source:
DateHeadline
Alector Inc (NASDAQ:ALEC) Insider Sells $32,000.00 in StockAlector Inc (NASDAQ:ALEC) Insider Sells $32,000.00 in Stock
www.americanbankingnews.com - August 21 at 6:21 PM
Short Interest in Alector Inc (NASDAQ:ALEC) Increases By 5.6%Short Interest in Alector Inc (NASDAQ:ALEC) Increases By 5.6%
www.americanbankingnews.com - August 15 at 9:09 AM
Contrasting Brainstorm Cell Therapeutics (NASDAQ:BCLI) and Alector (NASDAQ:ALEC)Contrasting Brainstorm Cell Therapeutics (NASDAQ:BCLI) and Alector (NASDAQ:ALEC)
www.americanbankingnews.com - August 15 at 4:14 AM
Alector Enters Oversold Territory (ALEC)Alector Enters Oversold Territory (ALEC)
www.nasdaq.com - August 14 at 8:38 PM
Alector (NASDAQ:ALEC) Announces  Earnings ResultsAlector (NASDAQ:ALEC) Announces Earnings Results
www.americanbankingnews.com - August 13 at 8:20 AM
BRIEF-Alector Reports Qtrly Loss Per Share $0.36BRIEF-Alector Reports Qtrly Loss Per Share $0.36
www.msn.com - August 13 at 1:19 AM
Ron Baron Comments on Adaptive Biotechnologies CorpRon Baron Comments on Adaptive Biotechnologies Corp
finance.yahoo.com - August 12 at 8:18 PM
Alector EPS misses by $0.03, misses on revenueAlector EPS misses by $0.03, misses on revenue
seekingalpha.com - August 12 at 8:18 PM
Alector Announces the Addition of Kristine Yaffe, M.D., to the Board of DirectorsAlector Announces the Addition of Kristine Yaffe, M.D., to the Board of Directors
finance.yahoo.com - August 12 at 12:35 PM
Orbimed Advisors Llc Sells 650,000 Shares of Alector Inc (NASDAQ:ALEC) StockOrbimed Advisors Llc Sells 650,000 Shares of Alector Inc (NASDAQ:ALEC) Stock
www.americanbankingnews.com - August 9 at 8:40 PM
Alector Inc (NASDAQ:ALEC) Given Consensus Rating of "Buy" by AnalystsAlector Inc (NASDAQ:ALEC) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - August 1 at 4:28 AM
Alector Announces Data from On-going Phase 1b Trial Demonstrating that AL001 Reverses Progranulin Deficiency in Frontotemporal Dementia PatientsAlector Announces Data from On-going Phase 1b Trial Demonstrating that AL001 Reverses Progranulin Deficiency in Frontotemporal Dementia Patients
finance.yahoo.com - July 18 at 10:43 AM
Alector Announces Upcoming Presentations at 2019 Alzheimers Association International ConferenceAlector Announces Upcoming Presentations at 2019 Alzheimer's Association International Conference
finance.yahoo.com - July 11 at 9:49 AM
Hedge Funds Have Never Been This Bullish On Alector, Inc. (ALEC)Hedge Funds Have Never Been This Bullish On Alector, Inc. (ALEC)
finance.yahoo.com - June 27 at 9:42 AM
Online Medical Market Astonishing Growth|Google, Alector, Collective HealthOnline Medical Market Astonishing Growth|Google, Alector, Collective Health
www.marketwatch.com - June 5 at 8:58 AM
Alector: Targeted Therapies For Neurodegenerative DiseasesAlector: Targeted Therapies For Neurodegenerative Diseases
seekingalpha.com - May 20 at 3:29 PM
Alector misses by $0.15, misses on revenueAlector misses by $0.15, misses on revenue
seekingalpha.com - May 14 at 5:21 AM
Alector Reports Recent Business Highlights and First Quarter 2019 Financial ResultsAlector Reports Recent Business Highlights and First Quarter 2019 Financial Results
finance.yahoo.com - May 14 at 5:21 AM
Alector: 1Q Earnings SnapshotAlector: 1Q Earnings Snapshot
finance.yahoo.com - May 14 at 5:21 AM
Alector to Present at the Bank of America Merrill Lynch Healthcare Conference on May 15, 2019Alector to Present at the Bank of America Merrill Lynch Healthcare Conference on May 15, 2019
finance.yahoo.com - May 9 at 7:54 AM
What Percentage Of Alector, Inc. (NASDAQ:ALEC) Shares Do Insiders Own?What Percentage Of Alector, Inc. (NASDAQ:ALEC) Shares Do Insiders Own?
finance.yahoo.com - May 8 at 3:27 PM
Alector Announces First Alzheimers Disease Patient Dosed in Phase 1b Study of AL002Alector Announces First Alzheimer's Disease Patient Dosed in Phase 1b Study of AL002
www.marketwatch.com - May 6 at 7:40 AM
Alector Announces First Alzheimer’s Disease Patient Dosed in Phase 1b Study of AL002Alector Announces First Alzheimer’s Disease Patient Dosed in Phase 1b Study of AL002
finance.yahoo.com - May 6 at 7:40 AM
Dosing underway in early-stage study of Alectors AL001 in severe dementiaDosing underway in early-stage study of Alector's AL001 in severe dementia
seekingalpha.com - April 18 at 7:25 AM
Alector Announces First Frontotemporal Dementia Patient Dosed in Phase 1b Study of AL001Alector Announces First Frontotemporal Dementia Patient Dosed in Phase 1b Study of AL001
finance.yahoo.com - April 18 at 7:25 AM
Seeking $86 million IPO, this Peninsula company is betting common bacteria plays role in Alzheimer'sSeeking $86 million IPO, this Peninsula company is betting common bacteria plays role in Alzheimer's
finance.yahoo.com - April 15 at 3:25 PM
Alector Inc.Alector Inc.
www.barrons.com - April 12 at 3:27 PM
Alector (ALEC) Initiates Phase I Alzheimers Study on AL003Alector (ALEC) Initiates Phase I Alzheimer's Study on AL003
finance.yahoo.com - April 4 at 5:13 AM
Alector Reports Recent Business Highlights and Fourth Quarter and Full Year 2018 Financial ResultsAlector Reports Recent Business Highlights and Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - March 27 at 6:42 AM
Alector: Addressing Neuroinflammation In Neurodegenerative Diseases With Potential For A CureAlector: Addressing Neuroinflammation In Neurodegenerative Diseases With Potential For A Cure
seekingalpha.com - March 2 at 5:37 AM
BRIEF-Orbimed Advisors LLC Reports 18.86 Percent Stake In Alector Inc As Of Feb 11 - SEC FilingBRIEF-Orbimed Advisors LLC Reports 18.86 Percent Stake In Alector Inc As Of Feb 11 - SEC Filing
www.msn.com - February 21 at 3:15 PM
This page was last updated on 8/25/2019 by MarketBeat.com Staff

Featured Article: What is a price target?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel